Pharma company AstraZeneca has publicly released preclinical data from more than 50 of its medicines in order to find new drug combinations for cancer treatments. The data AstraZeneca released will be used in a competition it created in partnership with the DREAM Challenge, a non-profit, collaborative community that runs crowdsourcing efforts for biology.
People who participate in the challenge...
Adherium Limited, a New Zealand company working on a smart inhaler, has raised $25.6 million ($35 million AU) in an initial public offering on the Australian Securities Exchange, including a $3 million investment from its partner pharma company AstraZeneca, which just last month announced a longterm commercialization agreement with the company.
Adherium makes a line of medical devices that...
AstraZeneca has partnered with New Zealand-based Adherium Limited, which offers a mobile-enabled inhaler, to incorporate digital health offerings into AstraZeneca’s patient support programs for people with COPD and asthma.
Adherium's Smartinhaler sends data on when medication was taken to mobile devices and desktop computers via Bluetooth. The platform is designed to help patients, caregivers,...
AstraZeneca has partnered with mobile-enabled health coaching services company Vida to launch an app, called Day-by-Day, that helps patients who are recovering from a heart attack, according to Fortune.
The app is not only designed to speed up the patient's recovery, but it also helps patients deal with trauma that they may feel after experiencing a heart attack. The app is currently part of a...
Cambridge-based online patient community business PatientsLikeMe is teaming up with Boston-area health system Partners HealthCare to provide information and insights from PLM's platform to Partners' patients.
“We’re excited to work with such an esteemed health system to help patients and their care teams have a more complete understanding of patients’ whole health experience, and to support...
Swedish clinical trial recruitment company Trialbee has raised $5 million in first-round funding from existing investors Industrifonden and Briban Invest. The company previously raised about $3.2 million in seed funding. The money will be used, among other things, to support Trialbee's entrance into the US market.
Trialbee provides mobile and web-based tools for clinical trial recruitment, online...
Boston-based patient network PatientsLikeMe announced two pieces of pharma news this week: a five-year research collaboration deal with AstraZeneca and the results of a multiple sclerosis wearable study conducted in collaboration with Biogen.
The PatientsLikeMe-AstraZeneca deal is similar to one the company struck with Genentech last Spring. AstraZeneca will have full access to PatientsLikeMe's...
Exco InTouch, the clinical trial technology vendor best known for its large-scale COPD program with AstraZeneca and the NHS trusts in England, has raised $5 million (3.2 million pounds). The round was led by Albion Ventures, according to British news site HealthInvestor. Scottish Equity Partners, Exco's largest shareholder, also contributed to the round.
The Nottingham, England-based company...
Pharmaceutical companies have a lot of apps in the market, and have been making apps for a long time, but their apps aren't seeing downloads and usage on par with the apps from other industries. That's the conclusion of a new report from Research2Guidance (R2G), which analyzed more than 725 apps from 11 pharma companies.
According to R2G, the top pharma companies have 65 apps in the Apple and...
A little over a year after completing a pilot study, pharmaceutical company AstraZeneca and Exco InTouch have launched a mobile-enabled program in the UK to help patients manage their chronic obstructive pulmonary disease (COPD), called Me&MyCOPD.
The program has three components -- a portal in which patients can connect with providers, a server on which information is saved and messages are...
